4//SEC Filing
Gengos Andrew 4
Accession 0001562180-25-001632
CIK 0001831363other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 6:12 PM ET
Size
5.8 KB
Accession
0001562180-25-001632
Insider Transaction Report
Form 4
Gengos Andrew
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-24+750,000→ 750,000 totalExercise: $3.73Exp: 2035-02-23→ Common Stock (750,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from February 24, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001563623
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 6:12 PM ET
- Size
- 5.8 KB